Core Insights - SBC Medical Group has entered the Thai market through a partnership with BLEZ ASIA Co., Ltd, aiming to expand its aesthetic medicine services in Asia, following its previous entry into Singapore [1][4] - The partnership will focus on establishing a new clinic in Bangkok that specializes in dermatological treatments, leveraging SBC's expertise and BLEZ's local presence [1][2] Company Overview - SBC Medical Group operates over 250 clinics globally, with more than 6 million patient visits annually, and aims to provide high-quality aesthetic medical services developed in Japan [2] - BLEZ ASIA, a Japanese-owned company, has over 10 years of experience in Bangkok and operates a diverse portfolio, including pharmacies and clinics, with an annual patient base of approximately 100,000 for pharmacies and 1,200 for clinics [3] Market Potential - Thailand's aesthetic medicine market was valued at approximately USD 372.24 million in 2024 and is projected to grow to USD 1.118 billion by 2033, with a compound annual growth rate (CAGR) of 13.51% from 2025 to 2033 [3] - The limited availability of "Japanese-quality" aesthetic treatments in Thailand presents significant opportunities for reliable medical groups to meet the growing demand for safe and consistent care [3] Strategic Goals - The partnership with BLEZ is part of SBC's broader strategy to establish a foothold among Japanese expatriates in Thailand and expand into the wider Thai market [2][4] - SBC aims to deliver high-level medical services and create a model for integrating Japan's advanced medical services into the local market [5]
SBC Medical Group Enters the Thai Market through Partnership with BLEZ